Adaptimmune Therapeutics PLC·4

Jul 3, 5:00 PM ET

Kerr Giles Francis Bertram 4

4 · Adaptimmune Therapeutics PLC · Filed Jul 3, 2019

Insider Transaction Report

Form 4
Period: 2019-07-02
Transactions
  • Award

    Option to purchase Ordinary Shares

    2019-07-02+124,000124,000 total
    Exercise: $0.61From: 2020-07-02Exp: 2029-07-02Ordinary Shares (124,000 underlying)
Footnotes (1)
  • [F1]The exercise price was converted from GBP0.48 based on an exchange rate of $U.S. 1.2638 to GBP1.00. The actual exercise price will be the pounds sterling amount.

Documents

1 file
  • 4
    a4.xmlPrimary

    4